PEDIATRICS Vol. 111 No. 4 April 2003, pp. 785-789
Efficacy of Methylprednisolone and Urokinase Pulse Therapy for Severe Henoch-Schönlein Nephritis
From the Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan
--> Objective. To evaluate the efficacy of methylprednisolone and urokinase pulse therapy (MUPT) for severe Henoch-Schönlein nephritis, we examined the clinical manifestation and prognosis of patients with MUPT on long-term observation.
Methods. We enrolled 56 patients with Henoch-schönlein nephritis who had been diagnosed with at least type IIIb from 1980 to 1998 on long-term observation and had been treated with MUPT. The clinical features, laboratory data, and pathologic findings between "pre-MUPT" and "post-MUPT," and the prognosis of these patients on long-term observation were retrospectively investigated.
Results. The mean urinary protein excretion after 6 months of treatment had decreased significantly compared with "pre-MUPT." Hypercoagulant state in "after the completion of urokinase pulse therapy" improved compared with "pre-MUPT." First renal biopsies were performed in all patients and second biopsies were performed in 27 patients. The activity index decreased significantly from 4.1 ± 1.9 at first biopsy to 2.5 ± 1.7 at second biopsy, while the chronicity index did not differ between first and second biopsy. None had renal insufficiency and renal survival rate was 100% for the decade.
Conclusions. Although uncontrolled, our study suggested that MUPT is effective for those patients with the risk of progression of their nephropathy, especially if started early during the course of the disease before the crescents become fibrous.
Key Words: Henoch-Schönlein nephritis methylprednisolone urokinase prognosis
Abbreviations: HSP, Henoch-Schönlein purpura MUPT, methylprednisolone and urokinase pulse therapy HSPN, Henoch-Schönlein nephritis Ig, immunoglobulin UK, urokinase MPT, methylprednisolone pulse therapy
2PI,
2 plasmin inhibitor 24hCcr, 24-hour creatinine clearance LM, light microscopy IF, immunofluorescence TAT, thrombin antithrombin III complex
Received for publication Apr 2, 2002; Accepted Sep 5, 2002.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
J I Shin, J M Park, Y H Shin, J S Lee, and H J Jeong Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schonlein nephritis in children J. Clin. Pathol., November 1, 2005; 58(11): 1147 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Yang, C.-F. Hung, C.-R. Hsu, L.-C. Wang, Y.-H. Chuang, Y.-T. Lin, and B.-L. Chiang A nationwide survey on epidemiological characteristics of childhood Henoch-Schonlein purpura in Taiwan Rheumatology, May 1, 2005; 44(5): 618 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawasaki, J. Suzuki, and H. Suzuki Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study Nephrol. Dial. Transplant., April 1, 2004; 19(4): 858 - 864. [Abstract] [Full Text] [PDF] |
||||
eLetters:
Read all eLetters
- Mesangial fibrinogen deposition in childhood Henoch-Schonlein nephritis
- Jae Seung Lee, et al.
- Pediatrics Online, 8 Jan 2006 [Full text]








